236 related articles for article (PubMed ID: 14636642)
21. Analysis of genes implicated in iron regulation in individuals presenting with primary iron overload.
Zaahl MG; Merryweather-Clarke AT; Kotze MJ; van der Merwe S; Warnich L; Robson KJ
Hum Genet; 2004 Oct; 115(5):409-17. PubMed ID: 15338274
[TBL] [Abstract][Full Text] [Related]
22. A novel SLC40A1 p.Y333H mutation with gain of function of ferroportin: A recurrent cause of haemochromatosis in China.
Zhang W; Xu A; Li Y; Zhao S; Zhou D; Wu L; Zhang B; Zhao X; Wang Y; Wang X; Duan W; Wang Q; Nan Y; You H; Jia J; Ou X; Huang J;
Liver Int; 2019 Jun; 39(6):1120-1127. PubMed ID: 30500107
[TBL] [Abstract][Full Text] [Related]
23. African Americans at risk for increased iron stores or liver disease.
Dawkins FW; Gordeuk VR; Snively BM; Lovato L; Barton JC; Acton RT; McLaren GD; Leiendecker-Foster C; McLaren CE; Adams PC; Speechley M; Harris EL; Jackson S; Thomson EJ
Am J Med; 2007 Aug; 120(8):734.e1-9. PubMed ID: 17679134
[TBL] [Abstract][Full Text] [Related]
24. A novel mutation in ferroportin implicated in iron overload.
Wallace DF; Dixon JL; Ramm GA; Anderson GJ; Powell LW; Subramaniam VN
J Hepatol; 2007 May; 46(5):921-6. PubMed ID: 17383046
[TBL] [Abstract][Full Text] [Related]
25. Transferrin receptor-2 (TFR2) mutation Y250X in Alabama Caucasian and African American subjects with and without primary iron overload.
Barton EH; West PA; Rivers CA; Barton JC; Acton RT
Blood Cells Mol Dis; 2001; 27(1):279-84. PubMed ID: 11358388
[TBL] [Abstract][Full Text] [Related]
26. Clinical and genetic heterogeneity in hereditary haemochromatosis: association between lymphocyte counts and expression of iron overload.
Porto G; Cardoso CS; Gordeuk V; Cruz E; Fraga J; Areias J; Oliveira JC; Bravo F; Gangaidzo IT; MacPhail AP; Gomo ZA; Moyo VM; Melo G; Silva C; Justiça B; de Sousa M
Eur J Haematol; 2001 Aug; 67(2):110-8. PubMed ID: 11722599
[TBL] [Abstract][Full Text] [Related]
27. Rare causes of hereditary iron overload.
Ponka P
Semin Hematol; 2002 Oct; 39(4):249-62. PubMed ID: 12382200
[TBL] [Abstract][Full Text] [Related]
28. Hemochromatosis and iron-overload screening in a racially diverse population.
Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
[TBL] [Abstract][Full Text] [Related]
29. Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3).
Cazzola M; Cremonesi L; Papaioannou M; Soriani N; Kioumi A; Charalambidou A; Paroni R; Romtsou K; Levi S; Ferrari M; Arosio P; Christakis J
Br J Haematol; 2002 Nov; 119(2):539-46. PubMed ID: 12406098
[TBL] [Abstract][Full Text] [Related]
30. Multi-organ iron overload in an African-American man with ALAS2 R452S and SLC40A1 R561G.
Sussman NL; Lee PL; Dries AM; Schwartz MR; Barton JC
Acta Haematol; 2008; 120(3):168-73. PubMed ID: 19066423
[TBL] [Abstract][Full Text] [Related]
31. Ferroportin disease: pathogenesis, diagnosis and treatment.
Pietrangelo A
Haematologica; 2017 Dec; 102(12):1972-1984. PubMed ID: 29101207
[TBL] [Abstract][Full Text] [Related]
32. Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3).
Devalia V; Carter K; Walker AP; Perkins SJ; Worwood M; May A; Dooley JS
Blood; 2002 Jul; 100(2):695-7. PubMed ID: 12091367
[TBL] [Abstract][Full Text] [Related]
33. Iron overload due to mutations in ferroportin.
De Domenico I; Ward DM; Musci G; Kaplan J
Haematologica; 2006 Jan; 91(1):92-5. PubMed ID: 16434376
[TBL] [Abstract][Full Text] [Related]
34. Novel mutations of the ferroportin gene (SLC40A1): analysis of 56 consecutive patients with unexplained iron overload.
Pelucchi S; Mariani R; Salvioni A; Bonfadini S; Riva A; Bertola F; Trombini P; Piperno A
Clin Genet; 2008 Feb; 73(2):171-8. PubMed ID: 18177470
[TBL] [Abstract][Full Text] [Related]
35. The role of genetic factors in patients with hepatocellular carcinoma and iron overload - a prospective series of 234 patients.
Funakoshi N; Chaze I; Alary AS; Tachon G; Cunat S; Giansily-Blaizot M; Bismuth M; Larrey D; Pageaux GP; Schved JF; Donnadieu-Rigole H; Blanc P; Aguilar-Martinez P
Liver Int; 2016 May; 36(5):746-54. PubMed ID: 26474245
[TBL] [Abstract][Full Text] [Related]
36. Long-term phlebotomy successfully alleviated hepatic iron accumulation in a ferroportin disease patient with a mutation in SLC40A1: a case report.
Nishina S; Tomiyama Y; Ikuta K; Tatsumi Y; Toki Y; Kato A; Kato K; Yoshioka N; Sasaki K; Hara Y; Hino K
BMC Gastroenterol; 2021 Mar; 21(1):111. PubMed ID: 33673803
[TBL] [Abstract][Full Text] [Related]
37. G80S-linked ferroportin disease: classical ferroportin disease in an Asian family and reclassification of the mutant as iron transport defective.
McDonald CJ; Wallace DF; Ostini L; Bell SJ; Demediuk B; Subramaniam VN
J Hepatol; 2011 Mar; 54(3):538-44. PubMed ID: 21094556
[TBL] [Abstract][Full Text] [Related]
38. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls.
Holmström P; Marmur J; Eggertsen G; Gåfvels M; Stål P
Gut; 2002 Nov; 51(5):723-30. PubMed ID: 12377814
[TBL] [Abstract][Full Text] [Related]
39. [Genetic iron overloads and hepatic insulin-resistance iron overload syndrome: an update].
Ruivard M
Rev Med Interne; 2009 Jan; 30(1):35-42. PubMed ID: 18584923
[TBL] [Abstract][Full Text] [Related]
40. African iron overload.
Gordeuk VR
Semin Hematol; 2002 Oct; 39(4):263-9. PubMed ID: 12382201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
